| Revenue: guided vs achieved | 25.00% achieved Guided 15.00%–20.00%, 25.0% above the top of the range; confirmed by management |
|---|---|
| Revenue guidance | 17.5% → 20.0% Raised by 2.5 percentage points |
| Management target | Revenue 20.0% FY27 |
| Revenue growth | 26.7% YoY growth, driven by 16.5% volume and higher radiology mix. |
|---|---|
| Margins | EBITDA margin expanded 350 bps to 44.1% due to operating leverage. |
| Demand visibility | Strong underlying demand for quality diagnostics; high-end radiology seeing robust traction. |
| Management confidence | High; management emphasized sustainable momentum across both core and new markets. |
Growth
Consolidated revenue grew 26.7% YoY, primarily volume-led (16.5%) with a favorable shift toward high-end radiology tests and a 3% boost from CGHS tariff revisions.
Outlook
Management raised revenue guidance to at least 20% for FY27, citing strong H1 momentum and network ramp-up.
Risks
High geographic concentration in Hyderabad (67% revenue) and potential execution risks in newer markets like Kolkata and Pune.
Last quarter's promises, checked
Delivered
- FY27 'high double digit' → Q2 rev +26.7% YoY, FY27 raised to ≥20% (= BEAT)
- EBITDA margin 'above 40%' → 44.1% (= BEAT)
- Surplus cash ~₹330 Cr → ₹355 Cr (= BEAT)
Partly delivered
- 9 hubs in 12 mo → 8 hubs by Q1 FY28 (= PARTIAL)
- Capex ₹190–195 Cr → ₹155–160 Cr for 8 hubs (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: VIJAYA. Summary written with AI assistance from the document.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,425.00
- Market cap
- ₹14,677 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 72.1×Sector 53.8×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,554 Mn (+26.7%), EBITDA ₹1,128 Mn (44.1% margin), PAT ₹595 Mn (23.3%). Strategy: hub-and-spoke densification, Bengaluru/Hyderabad hubs, Guwahati entry.
Vijaya Diagnostic Centre Results Update
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.
Vijaya Diagnostic Centre Other Announcement
Vijaya Diagnostic Centre Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This report details the share distribution among various shareholder categories.